1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-3658
  5. NDC Package Code: 0093-3658-40 Buprenorphine

NDC Package 0093-3658-40 Buprenorphine

Patch, Extended Release Transdermal - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-3658-40
Package Description:
4 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 168 h in 1 PATCH
Product Code:
0093-3658
Proprietary Name:
Buprenorphine
Non-Proprietary Name:
Buprenorphine
Substance Name:
Buprenorphine
Usage Information:
This medication is used to help relieve severe ongoing pain (such as due to arthritis, chronic back pain). Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (7.5, 10, 15, or 20 micrograms per hour patches) should be used only if you have been regularly taking moderate amounts of opioid pain medication. These strengths may cause overdose (even death) if used by a person who has not been regularly taking opioids. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.
11-Digit NDC Billing Format:
00093365840
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1432969 - buprenorphine 15 MCG/HR 7 Day Transdermal System
  • RxCUI: 1432969 - 168 HR buprenorphine 0.015 MG/HR Transdermal System
  • RxCUI: 1432969 - buprenorphine 15 MCG/HR Weekly Transdermal Patch
  • RxCUI: 1542997 - buprenorphine 7.5 MCG/HR 7 Day Transdermal System
  • RxCUI: 1542997 - 168 HR buprenorphine 0.0075 MG/HR Transdermal System
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Patch, Extended Release - A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form).
    Administration Route(s):
  • Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
    • Active Ingredient(s):
  • BUPRENORPHINE 15 ug/h
    • Pharmacologic Class(es):
  • Partial Opioid Agonist - [EPC] (Established Pharmacologic Class)
  • Partial Opioid Agonists - [MoA] (Mechanism of Action)
    • DEA Schedule:
    Schedule III (CIII) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA204937
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-26-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0093-3658-40?

    The NDC Packaged Code 0093-3658-40 is assigned to a package of 4 pouch in 1 carton / 1 patch in 1 pouch / 168 h in 1 patch of Buprenorphine, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is patch, extended release and is administered via transdermal form.

    Is NDC 0093-3658 included in the NDC Directory?

    Yes, Buprenorphine with product code 0093-3658 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on November 26, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0093-3658-40?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0093-3658-40?

    The 11-digit format is 00093365840. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20093-3658-405-4-200093-3658-40